Every material Form 8-K AmpliTech Group, Inc. has filed with the SEC since August 12, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
AmpliTech amended its Asset Purchase Agreement with Titan Crest, reducing the aggregate purchase price from $8 million to $7 million, and said it did not waive rights or claims against Titan. The company expects full-year 2026 revenue to exceed FY2025 revenue, but it declined to give a more precise estimate because certain Asian customers shifted deployment schedules, which affects shipment and revenue timing.
Amendment No. 2 reduced the aggregate APA purchase price by $1 million, from $8 million to $7 million; the company says rights and claims remain intact.
Expects 2026 revenue to exceed FY2025 revenue; certain Asian customers shifted deployment schedules, though orders have not been cancelled.
Approximately $17 million in current order backlog, and more than $17 million in 5G ORAN shipments completed since program inception.
Expects positive EBITDA in fiscal 2027 and improved ORAN margins beginning in 2027, after an initial program that accepted approximately $2 million in reduced profit.
AmpliTech Group reported unaudited second-quarter 2026 revenue of $8.07 million, up about 50.9% from $5.35 million in the first quarter, and gross profit of $2.25 million, up 161.2% year over year. The net loss widened to $3.09 million from $1.77 million a year earlier as research and development and selling, general and administrative spending increased. Shareholders also saw the July 22, 2026 close of the Series A Rights process, which brought approximately $20.12 million in net proceeds.
Q2 2026 revenue was $8.07 million, versus $5.35 million in Q1 2026.
Gross margin was 27.9%, compared with 48.0% in Q1 2026 and 7.8% in Q2 2025.
Net loss was $3.09 million, versus $1.77 million in Q2 2025; R&D expense was $1.37 million.
Series A Rights closed July 22, 2026, with approximately $21.92 million gross and $20.12 million net proceeds.
On August 6, 2026, AmpliTech entered into Amendment No. 2 to its asset purchase agreement with Titan Crest, LLC and an affiliate. The company said Titan's substantial delinquency in delivering products delayed its development work, including documentation for 5G ORAN radio products. The amendment lowers the purchase price from $8 million to $7 million, and the remaining $2 million is payable only after the design package is transferred and the manufacturing partner confirms it is suitable for full production.
Amendment No. 2 dated August 6, 2026 amends the asset purchase agreement dated March 26, 2025, as amended April 15, 2025.
Aggregate purchase price reduced from $8,000,000 to $7,000,000.
Remaining $2,000,000 to be paid as $1,000,000 in cash and $1,000,000 in restricted common stock, priced on the 30-trading-day VWAP before the Transfer.
Titan was released from most remaining covenants and indemnities, which the affiliate assumed; the company did not waive pre-amendment claims against Titan or the affiliate.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every AmpliTech Group, Inc. filing is on SEC EDGAR ↗. 8-K briefs of other companies →